ACTIVE SUBSTANCE / INN

MOGAMULIZUMAB-KPKC

Brand name(s): POTELIGEO
FDA LISTED
PRESCRIPTION
BLA761051
ACTIVE SUBSTANCE
Mogamulizumab-Kpkc
REGULATORS
FDA
SPONSORS / MAH
KYOWA KIRIN
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
POTELIGEOBLA761051KYOWA KIRINPrescription

FULL INTELLIGENCE ON MOGAMULIZUMAB-KPKC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →